Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3672484

Bio X Cell InVivoSIM Anti-Human PD-L1 (Avelumab biosimilar), 5 MG, 5 MG

Catalog No. NC3672484
Encompass_Preferred

InVivoSIM anti-human PD-L1 (Avelumab biosimilar) is a research-grade, non-therapeutic monoclonal antibody that targets human PD-L1 (CD274) and blocks PD-L1 interaction with PD-1 and CD80. Supplied for research use only. Store at 4C; do not freeze.

  • Non-therapeutic biosimilar monoclonal antibody matching therapeutic variable regions.
  • Targets human PD-L1 (CD274) and blocks PD-L1-PD-1 interactions.
  • Isotype: human IgG1, .
  • Formulation: PBS, pH 7.0, without stabilizers or preservatives.
  • Endotoxin: 0.5 EU/mg.
  • Purity: 95% by SDS-PAGE.
  • Aggregation: <5% by SEC.
  • Sterility ensured by 0.2 m filtration.
  • Available in multiple vial sizes including 5 mg.

Catalog No. NC3672484 Supplier Bio X Cell Supplier No. SIM0021R005MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

InVivoSIM anti-human PD-L1 (Avelumab biosimilar) is a research-grade, non-therapeutic monoclonal antibody that targets human PD-L1 (CD274) and blocks PD-L1 interaction with PD-1 and CD80. Supplied for research use only. Store at 4C; do not freeze.

  • Non-therapeutic biosimilar monoclonal antibody matching therapeutic variable regions.
  • Targets human PD-L1 (CD274) and blocks PD-L1-PD-1 interactions.
  • Isotype: human IgG1, .
  • Formulation: PBS, pH 7.0, without stabilizers or preservatives.
  • Endotoxin: 0.5 EU/mg.
  • Purity: 95% by SDS-PAGE.
  • Aggregation: <5% by SEC.
  • Sterility ensured by 0.2 m filtration.
  • Available in multiple vial sizes including 5 mg.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.